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Background
Traditionally antibody producing cells like hybridoma
cells sank into oblivion since other suspension cell lines
have captured the biopharmaceutical production market.
However, they are still of particular interest in academic
and industrial diagnostic research. Hence, fast and suffi-
cient antibody production is needed as proof of concept,
for toxicology and in vivo studies. Although, hybridoma
cultivation in fetal bovine serum (FBS) containing animal
derived ingredients, like contaminating IgG, is undesir-
able and leads to difficulties in purification. When redu-
cing the serum to a minimum other key components of
the FBS have to be replaced. Therefore, human insulin-
like growth factor (IGF) [1] and the surfactant Pluronic
F68 were supplemented to improve overall cell perfor-
mance and to reduce shear stress during shaking respec-
tively employing Design of Experiment (DoE)[2].
Compared to the original basal medium an improvement
in cell growth, viability and antibody titer was achieved.
These optimized inoculum conditions were used for sub-
sequent bioreactor fermentations. Furthermore, these
conditions were used in order to test feeding strategies.
For this purpose a fed-batch process with a double bolus
feed was simulated in shake flasks with two different glu-
cose feeding strategies - with and without Hyclone Cell
Boost 6 (CB6). Finally, the result from shake flasks could
be verified and improved antibody yield was achieved in
a controlled 2L fed-batch process.
Material and methods
DoE approach
DoE (Modde, Umetrics) was used to optimize the cultiva-
tion medium by varying the three factors, FBS (1-10%),
IGF (10 - 100 μg/L) and Pluronic (0.2 - 1 g/L). The cen-
tral composite face-centered design was applied to test
24 different medium compositions. Cells were cultivated
with a seeding density of 2 × 105 cells/mL for five days in
these media in 40 mL working volume in 125 mL shaker
flask. Cell concentration and viability was quantified
every day using an image-based cell counter (Cedex XS,
Roche) and were defined as response factors for DoE
analysis (table 1). Cultures grown with optimized condi-
tions were used as inoculum for subsequent bioreactor
fermentations.
Feeding strategy
Cells were seeded with 3 × 105 cells/mL in 35 mL working
volume in 125 mL shake flasks in optimized medium
(DMEM, 4.5 g/L glucose, 2 mM stable glutamine, 6% FBS,
100 μg/L IGF and 0.2 g/L Pluronic). The 1st triplicate was
cultivated without feeding as batch control. The 2nd tripli-
cate was fed with 20 mM glutamine and 20 g/L glucose.
The 3rd triplicate was fed with 14 g/L glucose in CB6
(Hyclone, Thermo Scientific) instead of usual glucose
feeding in medium. Substrates and metabolites, cell con-
centration and antibody titer were measured with a chemi-
cal analyzer (Konelab, Thermo Scientific), an image-based
cell counter (Cedex XS, Roche) and Protein A HPLC (Agi-
lent), respectively.
Fed-batch with and without Cell Boost 6
Both feeding strategies with and without CB6 were per-
formed again in a 2L bioreactor. The incolumn density
was 3 × 105 cells/mL. The main parameters were kept
constant at 1 mM glutamine and at 2 g/L glucose.
Results and discussion
DoE approach
A simple DoE approach with the three factors FBS, IGF
and Pluronic led to improved hybridoma cultivation
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conditions. In Table 1 viability and viable cell concentra-
tion are depicted from exponential phase for all 24
media on day 3. Additional controls were run to
improve the model like zero values for each factor and
various FBS concentrations. FBS could be reduced from
10% to 6% by adding 100 μg/L human insulin-like
growth factor and 0.2 g/L Pluronic. Compared to the
original base medium an improvement in cell growth
and viability was achieved.
Three concentration levels for each variable including a
maximum (1) a minimum (-1) and a center point (0) were
used. Values shown in parenthesis are concentrations. Exp
no 15-17 shows the central points for the medium, which
were repeated three times. Exp no 18-20 shows the zero
controls for each factor. Exp no 21-24 are additional con-
trols for FBS at different concentrations. The concentra-
tions in the yellow and red box are not in brackets.
Viability and viable cell concentration were determined as
response factors and used for fitting and evaluating the
model.
Based on the DoE results, the optimized medium was
compared to the original culture conditions with FBS
(10%, 6% and 1%) subsequently in 125mL shake flasks
in triplicates. Reduction of FBS without supplementation
results in decreased viability and cell concentration. The
optimized medium, compared to 10% FBS supplementa-
tion, showed a significant impact in viable cell concen-
tration and antibody titer by 1.2 fold.
Feeding strategy
After optimizing the inoculum conditions, a fed-batch
process was simulated in 125 mL shake flask due to a
daily bolus feed with glutamine and glucose. The batch
control ended in the death phase at day 3, whereas the
fed-batch feed led to 6 day cultivation time. The feeding
strategy with CB6 revealed a slightly improved cell
growth. This result could be tremendously improved in
a controlled 2L bioreactor leading to elongated process
time (6 to 12 days), an increased viable cell concentra-
tion (from 1.6 × 106 cells/mL to 6.4 × 106 cells/mL) and
higher antibody titer (450mg/L compared to initial
110mg/L) (Figure 1).
Fed-batch was started with optimized medium (DMEM
supplemented with 6% FBS, 100 μg/L IGF and 0.2 g/L
Pluronic). Glutamine was hold constant at 1 mM and
glucose at 2 g/L. Substrates and metabolites, cell concen-
tration and antibody titer were measured with a chemical
analyzer (Konelab, Thermo Scientific), an image-based
cell counter (Cedex XS, Roche) and Protein A HPLC
(Agilent) respectively each day.
Table 1 Central composite face-centered result
Exp No FBS [%] Pluronic [g/L] IGF [ug/L) Viability [%] Viable cell concentration [cells/mL]
1 -1 (1) -1 (0.2) -1 (10) 75.8 736000
2 1 (10) -1 (0.2) -1 (10) 79.1 1.468e+006
3 -1 (1) 1 (1) -1 (10) 66.6 575000
4 1 (10) 1 (1) -1 (10) 82 1.401e+006
5 -1 (1) -1 (0.2) 1 (100) 71.6 696000
6 1 (10) -1 (0.2) 1 (100) 77.9 1.545e+006
7 -1 (1) 1 (1) 1 (100) 59.3 554000
8 1 (10) 1 (1) 1 (100) 78.7 1.319e+006
9 -1 (1) 0 (0.6) 0 (55) 69.1 632000
10 1 (10) 0 (0.6) 0 (55) 79.8 1.455e+006
11 0 (5.5) -1 (0.2) 0 (55) 82.5 1.461e+006
12 0 (5.5) 1 (1) 0 (55) 78.9 1.442e+006
13 0 (5.5) 0 (0.6) -1 (10) 79.1 1.326e+006
14 0 (5.5) 0 (0.6) 1 (100) 81.6 1.336e+006
15 0 (5.5) 0 (0.6) 0 (55) 81.8 1.27e+006
16 0 (5.5) 0 (0.6) 0 (55) 80.2 1.194e+006
17 0 (5.5) 0 (0.6) 0 (55) 81.3 1.188e+006
18 0 0.6 55 28.5 13300
19 5.5 0 55 78.4 1.255e+006
20 5.5 0.6 0 81.25 1.2685e+006
21 5.5 0.2 100 83.7 1.533e+006
22 10 0 0 83.6 1.28e+006
23 6 0 0 81.9 1.305e+006
24 1 0 0 57.2 464000
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Conclusion
This data presents DoE as a powerful and efficient time
saving tool in process optimization as well as a novel
feeding strategy for fed-batch hybridoma process for
increased IgG production. By employing DoE, FBS could
be decreased from 10% to 6% by 100 μg/L human IGF
and 0.2 g/L Pluronic F68. For entirely serum-free hybri-
doma culture further critical ingredients like transferrin
and albumin have to be replaced. However, serum-free
media leads to higher production costs and can result in
antibody yield reduction. Optimized medium was suc-
cessfully used for subsequent bioreactor processes start-
ing with a better cell performance. Fed-batch feeding
with Hyclone Cell Boost 6 was beneficial for cell growth
and antibody production compared to the conventional
feed with glucose in medium. Both the optimized med-
ium as well as the Cell Boost 6 feeding strategy led to a
prolonged process time and increased antibody titer in
the fermentation process.
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Figure 1 Fed-batch process with double feed - glutamine in medium and glucose (F1: with CB6; F2: without CB6).
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